Company Profiles

driven by the PitchBook Platform

Targanox

2008 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$5.1M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of therapeutic drugs to prevent stress induced diseases. The company is focused on developing drugs to curb a disease-related biochemical condition called oxidative stress.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
37 Spinelli Place
Cambridge, MA 02138
United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Targanox’s full profile, request a free trial.

Targanox Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 30-Mar-2009 $5.1M 00.00 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Targanox Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Targanox Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ascent Biomedical Ventures Venture Capital Minority 000 0000 000000 0
Partners HealthCare Innovation Corporate Venture Capital Minority 000 0000 000000 0

Targanox Executive Team (7)

Name Title Board
Seat
Contact
Info
Ross Stein Ph.D Chief Scientific Officer
L. Gordon Letts Co-Founder & Chief Scientist
Kate Carroll Co-Founder
Avi Kometz MD Chief Executive Officer & Board Member
Joseph Loscalzo Ph.D Co-Founder & Board Member

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Targanox Board Members (4)

Name Representing Role Since Contact
Info
Avi Kometz MD Self Chief Executive Officer & Board Member 000 0000
Geoffrey Smith JD Ascent Biomedical Ventures Board Member 000 0000
Joseph Loscalzo Ph.D Self Co-Founder & Board Member 000 0000
Roger Kitterman Partners Healthcare Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com